Virpax Pharmaceuticals

$4.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-2.32%) Today
$0.00 (0.00%) As of 8:45 PM UTC after-hours

Why Robinhood?

You can buy or sell VRPX and other stocks, options, and ETFs commission-free!

About VRPX

Virpax Pharmaceuticals, Inc. engages in developing pharmaceutical products for pain management by using new drug delivery systems. Its products include DSF100, Probudur, Epoladerm and NES100.

CEO
Anthony P. Mack
Employees
4
Headquarters
West Chester, Pennsylvania
Founded
2017
Market Cap
23.47M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
370.42K
High Today
$4.72
Low Today
$4.55
Open Price
$4.71
Volume
38.30K
52 Week High
$8.24
52 Week Low
$4.28

VRPX Earnings

Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Jun 10, Pre-Market

You May Also Like

BVXV
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure